Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

16 results
Display

Chronicles of blood morphology associated with steroid use

Gaur K, Puri V, Shukla S, Sharma S

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Optimizing carfilzomib use in multiple myeloma treatment

Yoon SS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful treatment of non-IgM lymphoplasmacytic lymphoma by bortezomib-containing regimen: case reports and review of literature

Ito K, Nishiyama , Hirano K, Yamada K, Sekiguchi

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of follicular lymphoma accompanied with chylous ascites

Ohe M, Baba M, Shida H, Furuya K, Kogawa K

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neutrophil-erythrocyte rosettes in direct antiglobulin test-negative autoimmune hemolytic anemia

Park HS, Shin KS, Son BR

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characteristics and survival of patients with atypical chronic myeloid leukemia

Kong JH, Nam H, Go TH, Hyun SY, Shim KY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
High-grade nodal marginal zone lymphoma with diffuse bone marrow involvement and IgM-type monoclonal paraproteinemia: a case report and review of the literature

Park SH, Kim J, Jeong J, Lee SH, Cha HJ, Park SH, Choi Y, Jo JC, Lim JH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bone marrow metastasis of small cell lung carcinoma with spontaneous tumor lysis syndrome without hepatic metastasis at diagnosis: first case report in Korea and review of literature

Park SH, Lim JH, Jeong J, Lee SH, Cha HJ, Choi Y, Jo JC

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts

Fathi E, Sanaat Z, Farahzadi

Drug resistance in cancer, especially in leukemia, creates a dilemma in treatment planning. Consequently, studies related to the mechanisms underlying drug resistance, the molecular pathways involved in this phenomenon, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A

Kim JY, You CW

BACKGROUND: Risk factors for the development of inhibitors in previously untreated patients (PUPs) have been reported; this is not the case in previously treated patients (PTPs) owing to fewer studies....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura

Oh J, Oh D, Lee SJ, Kim JO, Kim NK, Chong SY, Huh JY, Baker RI, on behalf of the Korean TTP Registry Investigators

BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) involves dysregulation of the complement system, but whether this also occurs in thrombotic thrombocytopenic purpura (TTP) remains unclear. Although these conditions are difficult to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical features and treatment outcomes of Hodgkin lymphoma: A retrospective review in a Malaysian tertiary hospital

Boo YL, Ting HS, Yap DF, Toh SG, Lim SM

BACKGROUND: Classical Hodgkin lymphoma (cHL) is a clinicopathologically unique, aggressive lymphoma arising from germinal center B-cells and is one of the most curable hematological malignancies. This study aimed to determine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
HIV/AIDS-related lymphoma: perspective from a regional cancer center in India

Rudresha A, Khandare P, Lokanatha , Linu AJ, Suresh Babu MC, Lokesh KN, Rajeev LK, Smitha CS, Amale VB, Premalata , Nikita M

BACKGROUND: India has the third largest population of people living with HIV/AIDS (PLHA). Lymphoma is the second most common malignancy among PLHA. However, data are lacking regarding HIV/AIDS-related lymphoma (ARL)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Subgroup analysis of a phase 2/3 study of rurioctocog alfa pegol in patients with severe hemophilia A: efficacy and safety in previously treated Korean patients

You CW, Baek HJ, Park SK, Park YS, Shin HJ, Engl W, Tangada S

BACKGROUND: The efficacy and safety of extended half-life, full-length, pegylated recombinant factor VIII rurioctocog alfa pegol [BAX 855, ADYNOVATE (USA)/ADYNOVI (Europe); Baxalta US Inc., a Takeda company, Lexington, MA, USA]...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Favorable long-term survival using consolidation chemotherapy without allogeneic hematopoietic cell transplantation for acute myeloid leukemia with wild-type NPM1 without FLT3-ITD

Baek DW, Lee JM, Kim JH, Cho HJ, Ham JY, Suh JS, Sohn SK, Moon JH

BACKGROUND: The role of allogeneic hematopoietic cell transplantation (allo-HCT) compared with consolidation chemotherapy alone in intermediate-risk acute myeloid leukemia (AML) patients with wild-type nucleophosmin/negative or a low level of Fms...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study

Huang D, Wong E, Zuo ML, Chan PH, Yue WS, Hu HX, Chen L, Yin LX, Cui XW, Wu MX, Su X, Siu CW, Hai JJ

BACKGROUND: Previous Caucasian studies have described venous thromboembolism in pregnancy; however, little is known about its incidence during pregnancy and early postpartum period in the Chinese population. We investigated the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr